Literature DB >> 18379333

Early effects of electroconvulsive therapy on cognitive function.

Richard Porter1, Helen Heenan, Jo Reeves.   

Abstract

OBJECTIVE: Routine screening of cognitive function during a course of electroconvulsive therapy (ECT) is recommended in several guidelines. However, there is little evidence regarding which measures are practical, change early in treatment, and are likely to predict longer term cognitive problems. We aimed to investigate the practicality of early formal cognitive screening in routine clinical practice of ECT.
METHODS: Thirty-three patients aged 25 to 84 years were recruited from 2 ECT clinics. Assessment consisted of the Rey Verbal Learning Test (RAVLT), The Short Form of the Colombia University Autobiographical Memory Interview, Digit Span Forwards and Backwards, and Modified Mini-Mental State Examination (3MSE) and was conducted at baseline, between the third and the fourth treatment of ECT and 2 months after the last treatment. Analysis examined which measures changed after 3 treatments and whether this correlated with change at the 2 month follow-up.
RESULTS: After 3 treatments, there was a significant reduction in immediate (F1,27 = 14; P = 0.001) and 30-minute delayed (F1,25 = 34; P < 0.001) recall of the RAVLT. There was also a significant reduction in autobiographical memory score but no significant change in digit span or 3MSE. There was no correlation between reductions in scores on the RAVLT and The Short Form of the Colombia University Autobiographical Memory Interview, after 3 treatments and reductions at 2 month follow-up.
CONCLUSIONS: This small pilot study suggests that significant changes in memory function can be detected as early as after 3 treatments of ECT and that such monitoring can be done in routine clinical practice. There was, however, no evidence that these changes correlated with longer term changes.

Entities:  

Mesh:

Year:  2008        PMID: 18379333     DOI: 10.1097/YCT.0b013e31816207f0

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  5 in total

1.  A systematic review of the neurocognitive effects of magnetic seizure therapy.

Authors:  Shawn M McClintock; Owais Tirmizi; Matthieu Chansard; Mustafa M Husain
Journal:  Int Rev Psychiatry       Date:  2011-10

2.  Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).

Authors:  Liam Trevithick; R Hamish McAllister-Williams; Andrew Blamire; Tim Branton; Ross Clark; Darragh Downey; Graham Dunn; Andrew Easton; Rebecca Elliott; Clare Ellwell; Katherine Hayden; Fiona Holland; Salman Karim; Jo Lowe; Colleen Loo; Rajesh Nair; Timothy Oakley; Antony Prakash; Parveen K Sharma; Stephen R Williams; Ian M Anderson
Journal:  BMC Psychiatry       Date:  2015-10-21       Impact factor: 3.630

3.  Anterograde Amnesia during Electroconvulsive Therapy: A Prospective Pilot-Study in Patients with Major Depressive Disorder.

Authors:  Elvira Boere; Astrid M Kamperman; Arianne E van 't Hoog; Walter W van den Broek; Tom K Birkenhäger
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

4.  Cognitive side-effects of electroconvulsive therapy: what are they, how to monitor them and what to tell patients.

Authors:  Richard J Porter; Bernhard T Baune; Grace Morris; Amber Hamilton; Darryl Bassett; Philip Boyce; Malcolm J Hopwood; Roger Mulder; Gordon Parker; Ajeet B Singh; Tim Outhred; Pritha Das; Gin S Malhi
Journal:  BJPsych Open       Date:  2020-04-17

5.  Impact of Sevoflurane and Thiopental Used Over the Course of Electroconvulsive Therapy: Propensity Score Matching Analysis.

Authors:  Taisuke Yatomi; Takahito Uchida; Akihiro Takamiya; Masataka Wada; Shun Kudo; Kazuki Nakajima; Hana Nishida; Bun Yamagata; Masaru Mimura; Jinichi Hirano
Journal:  Front Hum Neurosci       Date:  2022-07-08       Impact factor: 3.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.